Danish agency reviews medicines containing dibutyl phthalate
This article was originally published in SRA
The Danish Medicines Agency is reviewing all medicines on the market that contain the plasticiser dibutyl phthalate1. DBP is used as an excipient in the coating of medicines, among other things.
You may also be interested in...
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.